Managed Healthcare Executive September 6, 2024
Kerri Tanner, Pharm.D., the chief pharmacy officer of PayerAlly, says payers are looking for ways to rein in the escalating costs of specialty pharmacy drugs beyond the traditional techniques used by pharmacy benefit managers.
First. here is the obvious one: the rising cost of specialty drugs and their growing share of the “drug spend,” although that trend has been blunted a bit by the glucagon-like peptide 1 (GLP-1) drugs.
Second, says Kerri Tanner, Pharm.D.,is a desire for new ways of controlling those costs beyond the “one...
Today's Sponsors
Today's Sponsor